TCI Wealth Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-337
Closed 1650
2019
Q1
$0 Hold
337
﹤0.01% 1652
2018
Q4
$0 Hold
337
﹤0.01% 1816
2018
Q3
$0 Hold
337
﹤0.01% 1697
2018
Q2
$0 Hold
337
﹤0.01% 1701
2018
Q1
$0 Hold
337
﹤0.01% 1502
2017
Q4
$0 Hold
337
﹤0.01% 1489
2017
Q3
$0 Hold
337
﹤0.01% 1440
2017
Q2
$0 Hold
337
﹤0.01% 1442
2017
Q1
$0 Hold
337
﹤0.01% 1482
2016
Q4
$0 Sell
337
-78
-19% -$26 ﹤0.01% 1534
2016
Q3
$0 Hold
415
﹤0.01% 1481
2016
Q2
$0 Hold
415
﹤0.01% 1497
2016
Q1
$0 Hold
415
﹤0.01% 1503
2015
Q4
$0 Hold
415
﹤0.01% 1146
2015
Q3
$0 Hold
415
﹤0.01% 1078
2015
Q2
$0 Buy
+415
New +$287 ﹤0.01% 1057
2015
Q1
Sell
-2,415
Closed -$2K 1025
2014
Q4
$2K Buy
2,415
+1,974
+448% +$1.35K ﹤0.01% 784
2014
Q3
$0 Sell
441
-3,919
-90% -$1.9K ﹤0.01% 958
2014
Q2
$2K Hold
4,360
﹤0.01% 803
2014
Q1
$1K Hold
4,360
﹤0.01% 876
2013
Q4
$1K Hold
4,360
﹤0.01% 852
2013
Q3
$9K Hold
4,360
0.01% 402
2013
Q2
$8K Buy
+4,360
New +$7.66K 0.01% 405

Other funds holding GCVRZ

TCI Wealth Advisors's GCVRZ Position: Q2 2019 in Review

TCI Wealth Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2019, closing a stake of 337 shares.

TCI Wealth Advisors first reported a position in GCVRZ in Q2 2013 and held it in 23 quarters. The position peaked at $9K in Q3 2013. 104 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2019.

  • TCI Wealth Advisors reported no remaining Sanofi Contingent Value Rights position as of Q2 2019 after selling out during the quarter.
  • TCI Wealth Advisors sold 337 Sanofi Contingent Value Rights shares in Q2 2019.
  • TCI Wealth Advisors first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 23 quarters.
  • TCI Wealth Advisors's Sanofi Contingent Value Rights position peaked at $9K in Q3 2013.
  • 104 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2019.

Based on TCI Wealth Advisors's 13F filing for Q2 2019, filed 23 Jul 2019.